NATCO Pharma Limited

NSEI:NATCOPHARM Rapport sur les actions

Capitalisation boursière : ₹277.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

NATCO Pharma Dividende

Dividende contrôle des critères 4/6

NATCO Pharma est une société versant des dividendes avec un rendement actuel de 0.66% qui est bien couvert par les bénéfices. La prochaine date de paiement est le 11th September, 2024 avec une date ex-dividende de 23rd August, 2024.

Informations clés

0.6%

Rendement du dividende

6%

Ratio de distribution

Rendement moyen de l'industrie0.7%
Prochaine date de paiement du dividende11 Sep 24
Date ex-dividende23 Aug 24
Dividende par action₹9.500
Résultat par action₹91.37
Prévisions de rendement du dividende à 3 ans0.3%

Mises à jour récentes des dividendes

NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25

Feb 21
NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25

Recent updates

NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market

Aug 13
NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market

If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity

Jul 15
If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity

NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly

Jun 30
NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly

NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors

Jun 14
NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors

NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

May 30
NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)

May 09
Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)

Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?

Apr 03
Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?

NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25

Feb 21
NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25

NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next

Feb 18
NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next

NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Feb 17
NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement

Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?

Jan 25
Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?

An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued

Jan 09
An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued

Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?

Dec 13
Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued

Sep 30
An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued

Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today

Sep 12
Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today

NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year

Aug 12
NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year

Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?

Jul 16
Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?

NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate

Apr 20
NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate

Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?

Dec 20
Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?

NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's

Aug 12
NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's

Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?

Jun 23
Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?

Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher

Jun 02
Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher

NATCO Pharma's (NSE:NATCOPHARM) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 22
NATCO Pharma's (NSE:NATCOPHARM) Shareholders Will Receive A Bigger Dividend Than Last Year

Estimating The Intrinsic Value Of NATCO Pharma Limited (NSE:NATCOPHARM)

Feb 16
Estimating The Intrinsic Value Of NATCO Pharma Limited (NSE:NATCOPHARM)

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: Les paiements de dividendes de NATCOPHARM ont été volatils au cours des 10 dernières années.

Dividende croissant: Les paiements de dividendes de NATCOPHARM ont augmenté au cours des 10 dernières années.


Rendement des dividendes par rapport au marché

NATCO Pharma Rendement des dividendes par rapport au marché
Comment le rendement du dividende de NATCOPHARM se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (NATCOPHARM)0.6%
25% du marché (IN)0.2%
25% du marché (IN)1.1%
Moyenne du secteur (Pharmaceuticals)0.7%
Prévisions des analystes dans 3 ans (NATCOPHARM)0.3%

Dividende notable: Le dividende de NATCOPHARM ( 0.66% ) est supérieur à celui des 25 % des payeurs de dividendes les plus faibles du marché Indian ( 0.25% ).

Dividende élevé: Le dividende de NATCOPHARM ( 0.66% ) est faible par rapport aux 25 % des premiers payeurs de dividendes du marché Indian ( 1.08% ).


Bénéfice distribué aux actionnaires

Couverture des revenus: Avec son faible taux de distribution ( 6% ), les paiements de dividendes de NATCOPHARM sont entièrement couverts par les bénéfices.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: Avec son faible taux de distribution de dividendes ( 20% ), les paiements de dividendes de NATCOPHARM sont bien couverts par les flux de trésorerie.


Découvrir des entreprises qui versent des dividendes élevés